RxDoctor Payments Data

Thanh Barbie, MD

Surgical Oncology · Boston, MANPI 1770615809

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $108,000 of the $108,000 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Qiagen, LLC. Among surgical oncology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$108,000in general payments, 2019–2025

Across 71 payments — averaging $1521.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Qiagen, LLC$108K

What the payments were for

  • Consulting fees$108,000100%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Qiagen, LLC71$108,000

How this compares

$108,000 in reported general payments places this provider in the 95th percentile of 55 surgical oncology providers in Massachusetts.

See all surgical oncology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$83,525
Medicare patients
85
Services billed
270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →